Philogen S.p.A. (BIT:PHIL)
22.85
-0.35 (-1.51%)
May 28, 2026, 4:55 PM CET
Philogen Revenue
In the year 2025, Philogen had annual revenue of 319.73M EUR with 313.81% growth. Philogen had revenue of 311.20M in the half year ending December 31, 2025, with 12,856.04% growth.
Revenue
319.73M
Revenue Growth
+313.81%
P/S Ratio
2.92
Revenue / Employee
1.49M
Employees
214
Market Cap
934.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 319.73M | 242.47M | 313.81% |
| Dec 31, 2024 | 77.26M | 52.53M | 212.42% |
| Dec 31, 2023 | 24.73M | -2.21M | -8.20% |
| Dec 31, 2022 | 26.94M | 21.98M | 442.71% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| Safilo Group | 983.38M |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Svas Biosana | 141.56M |
Philogen News
- 15 days ago - Philogen Earnings release: Q1 2026 - Filings
- 2 months ago - Philogen Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Philogen Annual report: H2 2025 - Filings
- 2 months ago - Philogen Earnings release: H2 2025 - Filings
- 7 months ago - Philogen Earnings release: Q3 2025 - Filings
- 8 months ago - Philogen Earnings Call Transcript: H1 2025 - Transcripts
- 8 months ago - Philogen Quarterly report: H1 2025 - Filings
- 8 months ago - Philogen Earnings release: H1 2025 - Filings